Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 134 publications
COMMIT: A Randomized Study of mFOLFOX6/Bevacizumab/Atezolizumab or Atezolizumab Alone as First-Line Treatment of Deficient DNA Mismatch Repair Metastatic Colorectal Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 29, 2026
DART (NCI/SWOG S1609): comprehensive final results from dual checkpoint inhibition with CTLA-4 and PD-1 blockade in rare cancers.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: February 25, 2026
DART/SWOG/NCI phase II anti-CTLA-4/PD-1 trial: clear cell carcinomas of ovary, endometrium, cervix.
Journal: Journal for immunotherapy of cancer
Published: January 20, 2026
PROSPECT-LUNG: A National Clinical Trials Network Trial Advancing Pragmatic Innovation in Cancer Clinical Trials.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: November 04, 2025
Multicenter phase II trial of ipilimumab and nivolumab in metastatic or unresectable perivascular epithelioid cell tumor (PEComa): a substudy of Dual Anti-CTLA-4 and Anti-PD-1 blockade in Rare Tumors (DART) SWOG S1609 (Cohort 38).
Journal: Journal for immunotherapy of cancer
Published: October 01, 2025
Phase II basket trial of Dual Anti-CTLA-4 and anti-PD-1 blockade in Rare Tumors (DART) SWOG S1609: pancreatic neuroendocrine neoplasm (PNEN) cohort.
Journal: Journal for immunotherapy of cancer
Published: June 06, 2025
Outcomes for FOLFIRI plus bevacizumab or cetuximab in patients treated with oxaliplatin-based adjuvant therapy: A combined analysis of FIRE-3 and CALGB/SWOG 80405 (Alliance).
Journal: European journal of cancer (Oxford, England : 1990)
Published: June 05, 2025
A phase II basket trial of DART SWOG S1609: the salivary gland tumor cohort.
Journal: Therapeutic advances in medical oncology
Published: April 04, 2025
Correlative Science in the Cooperative Group System: Re-Engineering for Success.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 17, 2024
Dual anti-CTLA-4 and anti-PD-1 blockade in metastatic basal cell carcinoma.
Journal: NPJ precision oncology
Published: August 20, 2024
Phase II basket trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART) SWOG S1609: the desmoid tumors.
Journal: Journal for immunotherapy of cancer
Published: July 29, 2024
A phase II basket trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART) SWOG S1609: durable responses and delayed pseudoprogression in small cell carcinoma of the ovary, hypercalcemic type cohort.
Journal: Cancer communications (London, England)
Published: July 16, 2024
Last Updated: 09/26/2026